doxium and retinopathy in diabetic patients
Phase 2
- Conditions
- Diabetic retinopathy.Retinal disorders in diseases classified elsewhere
- Registration Number
- IRCT20220817055729N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with non-proliferative diabetic retinopathy
Exclusion Criteria
other systemic disease except for diabetes
Other comorbid conditions such as CNV, RVO, Glaucoma etc.
Pregnancy
Lactation
The history of severe psychiatric illnesses such as schizophrenia, mood disorders, borderline disorders.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Macular thickness. Timepoint: before and 6 months of treatment. Method of measurement: Macular OCT (Optical Coherence Tomography).;Visual Equity. Timepoint: before and 6 months of treatment. Method of measurement: Snellen chart.
- Secondary Outcome Measures
Name Time Method